Trending Now
What Lies Ahead for the $150B Ad Industry (CMGR, ROKU, VIAC,...
There’s $150 billion in annual spending that has become homeless. It now wanders around the global economy, aimless, lost, searching for a...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Atossa Therapeutics Inc. (NASDAQ: ATOS) Acknowledges Breast Cancer Awareness Month And...
Atossa Therapeutics Inc. (NASDAQ: ATOS) has released a video message acknowledging Breast Cancer Awareness Month and encouraging women to go for mammograms.
Pandemic affecting breast...
MAKE IT MODERN
LATEST REVIEWS
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has Acquired New R&D Center
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) announced that the group had acquired a new research and development center, measuring close to 48,000 square feet;...
MAKE IT MODERN
PERFORMANCE TRAINING
The US Flirts with SPR Release but Energy Trend Points Higher (HP, HNRC, PDCE,...
The U.S. is eying the controversial step of tapping the Strategic Petroleum Reserve, a foundational deposit of oil housed in the US...
High-frequency trading during the holiday season
There always exists a conflict between investors and traders. One extracts inefficiencies in transactions while the other attempts to define value. Technological...
Zeeland Pharma A/S (NASDAQ: ZEAL) Doses First Subject in Phase 3b Study Evaluating Glepaglutide...
Zeeland Pharma A/S (NASDAQ: ZEAL) has announced the dosing of the first participants in the Phase 3b study, EASE-SBS 4, assessing glepaglutide, a long-acting...
Plus Therapeutics Inc. (NASDAQ: PSTV) and RadioMedix Inc. Enter Strategic Commercial Agreement For Radiopharmaceuticals...
Plus Therapeutics Inc. (NASDAQ: PSTV) has announced a commercial agreement with RadioMedix Inc. for the production of its radiopharmaceuticals.
Plus Therapeutics enters agreement with RadioMedix
Marc...
FDA Issues Positive Opinion On Citius Pharmaceuticals Inc.‘s (NASDAQ:CTXR) Proposed Mino-Lok Therapy Catheter Compatibility...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) has announced that the FDA has given a positive opinion regarding its proposed plan of studying catheter compatibility for its...
MAKE IT MODERN
